Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Appointed director
CC transcript
Auditor change
|
|
Vaxart, Inc. (VXRT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/30/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/25/2022 |
3
| HERON ELAINE J (Director) has filed a Form 3 on Vaxart, Inc. |
| 08/08/2022 |
3
| Watson W. Mark (Director) has filed a Form 3 on Vaxart, Inc. |
| 05/12/2022 |
3
| Ahmad Fuad (Interim CFO) has filed a Form 3 on Vaxart, Inc. |
| 02/22/2022 |
3
| Berg Edward B (SVP, General Counsel) has filed a Form 3 on Vaxart, Inc. |
| 10/07/2021 |
3
| Cummings James F. (Chief Medical Officer) has filed a Form 3 on Vaxart, Inc. |
| 08/23/2021 |
3
| Cherrington Julie M (Director) has filed a Form 3 on Vaxart, Inc. |
| 04/23/2021 |
3
| Wheadon David E. (Director) has filed a Form 3 on Vaxart, Inc. |
| 08/27/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/14/2020 |
3
| Floroiu Cezar Andrei (Director) has filed a Form 3 on Vaxart, Inc. |
| 11/01/2019 |
3
| Yedid Robert A. (Director) has filed a Form 3 on Vaxart, Inc. |
| 11/01/2019 |
3
| Maher Illya Keith (Director) has filed a Form 3 on Vaxart, Inc. |
| 11/01/2019 |
3
| Davis Todd C (Director) has filed a Form 3 on Vaxart, Inc. |
| 09/30/2019 |
3
| ARMISTICE CAPITAL, LLC (10% Owner) has filed a Form 3 on Vaxart, Inc. |
| 01/04/2019 |
3
| Echerd Margaret (VP, Corporate Controller, PAO) has filed a Form 3 on Vaxart, Inc. |
| 02/14/2018 |
3
| Life Science Angel Investors III, LLC (10% Owner) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| Latour Wouter (President and Chief Executive) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| Harland John M (CFO) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| Finney Michael J. (Director) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| Tucker Sean (Chief Scientific Officer) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| LESCHLY JAN (10% Owner) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| Markham Richard J (10% Owner) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 02/14/2018 |
3
| Care Capital III LLC (10% Owner) has filed a Form 3 on Aviragen Therapeutics, Inc. |
| 12/02/2013 |
3
| Azzarello Peter (Chief Accounting Officer) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 05/03/2013 |
3
| VANLENT ANNE (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 05/03/2013 |
3
| DOUGHERTY MICHAEL R (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/19/2012 |
3
| Hill Richard James (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/19/2012 |
3
| Gust Ian D. (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/19/2012 |
3
| Fox James (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/19/2012 |
3
| Errington Jeffery (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/19/2012 |
3
| Cook Peter Chapman (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/19/2012 |
3
| Bell Paul Ronald (Director) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/14/2012 |
3
| PLUMB RUSSELL H (CEO & President) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
| 11/14/2012 |
3
| PATTI JOSEPH M (EVP, Corporate Dev & Strategy) has filed a Form 3 on Biota Pharmaceuticals, Inc. |
|
|